Abstract
Peptides and proteins have been known for more than a century, but was only when du Vigneaud published the first synthesis of oxytocin, that the research on bioactive peptides was truly launched. Since then, the scientific progresses in the field have been astonishing and the synthesis of peptides of virtually any size and complexity is now possible. Perhaps the most important milestone was the development of the solid-phase peptide synthesis (SPPS) by Merrifield (1963), to revolutionize the field. In this critic review, we will analyze how the SPPS contributed to widespread the manufacture of peptides as active pharmaceuticals and what will be the challenges of tomorrow in this field.
Keywords: SPPS, LPPS, fmoc-chemistry, molecular machine, native chemical ligation.
Current Bioactive Compounds
Title:The Evolution of Peptide Synthesis: From Early Days to Small Molecular Machines
Volume: 9 Issue: 3
Author(s): Adriano Mollica, Francesco Pinnen, Stefanucci Azzurra and Roberto Costante
Affiliation:
Keywords: SPPS, LPPS, fmoc-chemistry, molecular machine, native chemical ligation.
Abstract: Peptides and proteins have been known for more than a century, but was only when du Vigneaud published the first synthesis of oxytocin, that the research on bioactive peptides was truly launched. Since then, the scientific progresses in the field have been astonishing and the synthesis of peptides of virtually any size and complexity is now possible. Perhaps the most important milestone was the development of the solid-phase peptide synthesis (SPPS) by Merrifield (1963), to revolutionize the field. In this critic review, we will analyze how the SPPS contributed to widespread the manufacture of peptides as active pharmaceuticals and what will be the challenges of tomorrow in this field.
Export Options
About this article
Cite this article as:
Mollica Adriano, Pinnen Francesco, Azzurra Stefanucci and Costante Roberto, The Evolution of Peptide Synthesis: From Early Days to Small Molecular Machines, Current Bioactive Compounds 2013; 9 (3) . https://dx.doi.org/10.2174/157340720903140119151919
DOI https://dx.doi.org/10.2174/157340720903140119151919 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Fight Against Drug-Resistant Malaria: Novel Plasmodial Targets and Antimalarial Drugs
Current Medicinal Chemistry The 1,4-Dihydropyridine Nucleus: A Pharmacophoric Template Part 1. Actions at Ion Channels
Mini-Reviews in Medicinal Chemistry The Effects of Sarcopenia on Muscles with Different Recruitment Patterns and Myofiber Profiles
Current Aging Science Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology
Current Drug Discovery Technologies Alzheimer’s Drug Discovery Maze: A Snap View of the Past Decade’s Diverse Pharmacological Targets for the Disorder
Mini-Reviews in Medicinal Chemistry Conference Report: 182nd AAAS Annual Meeting, Washington DC, February 11-15, 2016
CNS & Neurological Disorders - Drug Targets The Position of Endoscopic Procedures in the Treatment of Obesity
Current Clinical Pharmacology Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome (ARDS)
Current Pharmaceutical Design Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimers Disease
Current Alzheimer Research Oxidation Inhibits Iron-Induced Blood Coagulation
Current Drug Targets A Review of Micro/Nano Welding and Its Future Developments
Recent Patents on Nanotechnology The Roles of the PDZ-containing Proteins Bridge-1 and PDZD2 in the Regulation of Insulin Production and Pancreatic Beta-Cell Mass
Current Protein & Peptide Science Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair
CNS & Neurological Disorders - Drug Targets Structure and Enzymology of ADP-ribosyl Cyclases: Conserved Enzymes that Produce Multiple Calcium Mobilizing Metabolites
Current Molecular Medicine Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Re-Discovering PDE3 Inhibitors - New Opportunities for a Long Neglected Target
Current Topics in Medicinal Chemistry Treatment of Atopic Dermatitis: Current Status and Future Prospects
Current Drug Therapy Glucolipotoxicity-induced Oxidative Stress is Related to Mitochondrial Dysfunction and Apoptosis of Pancreatic β-cell
Current Diabetes Reviews Importance and Potential of Dentists in Identifying Patients at High Risk of Diabetes
Current Diabetes Reviews